Investigation of distinct gene expression profile patterns that can improve the classification of intermediate-risk prognosis in AML patients

dc.contributor.authorEshibona, N
dc.date.accessioned2023-03-30T10:27:35Z
dc.date.available2023-03-30T10:27:35Z
dc.date.issued2023
dc.description.abstractAcute myeloid leukemia (AML) is a heterogeneous type of blood cancer that generally affects the elderly. AML patients are categorized with favorable-, intermediate-, and adverse risks based on an individual’s genomic features and chromosomal abnormalities. Despite the risk stratification, the progression and outcome of the disease remain highly variable. To facilitate and improve the risk stratification of AML patients, the study focused on gene expression profiling of AML patients within various risk categories.en_US
dc.identifier.citationEshibona, N., Livesey, M. and Christoffels, A., 2023. Investigation of distinct gene expression profile patterns that can improve the classification of intermediate-risk prognosis in AML patients.en_US
dc.identifier.issn1664-8021
dc.identifier.urihttp://hdl.handle.net/10566/8709
dc.language.isoenen_US
dc.publisherFrontiers In Geneticsen_US
dc.subjectacute myeloid leukemiaen_US
dc.subjectrisk classificationen_US
dc.subjectintermediate-risken_US
dc.subjectgene expressionen_US
dc.subjectprognosisen_US
dc.titleInvestigation of distinct gene expression profile patterns that can improve the classification of intermediate-risk prognosis in AML patientsen_US
dc.typeArticleen_US

Files

Original bundle
Now showing 1 - 1 of 1
Loading...
Thumbnail Image
Name:
Eshibona_Investigation_of_distinct_gene_2023.pdf
Size:
3.22 MB
Format:
Adobe Portable Document Format
Description:
License bundle
Now showing 1 - 1 of 1
No Thumbnail Available
Name:
license.txt
Size:
1.71 KB
Format:
Item-specific license agreed upon to submission
Description: